Table 3.
Mean DAS28 | 4.68±1.86 |
---|---|
Median DAS28 | 4.65±3.44 |
Disease duration | 12.8±9.6 |
TNF-inhibitor (% yes) | 35% |
Methotrexate (% yes) | 75% |
Other Biologic (% yes) | 20% |
Other non-biologic DMARD (% yes) | 23% |
Prednisone use (% yes) | 23% |
DAS28, disease activity score using a 28 joint count (median DAS28±IQR, mean DAS28±SD); DMARD, disease-modifying antirheumatic drug; TNF, tumour necrosis factor.